Megavac Cc Canine Corona Vaccine

Description

Megavac-CC is a vaccine designed to provide active immunization against canine coronavirus (CCoV) infections in dogs. This vaccine, developed by Indian Immunologicals Limited (IIL), helps protect dogs from the enteric form of the virus, which primarily affects the gastrointestinal tract and can lead to symptoms like diarrhea and vomiting.
Here’s a summary of key information about Megavac-CC:
1. Composition
It contains a tissue culture-adapted strain of the Canine Coronavirus, grown on A-72 cell lines.
This virus is inactivated with ?-propiolactone.
Aluminum hydroxide gel is used as an adjuvant to enhance the immune response.
2. Indications and use
For active immunization against canine coronavirus disease in dogs.
It’s important to note that Megavac-CC targets the enteric form of CCoV, which causes gastrointestinal problems, and is not the same as the virus that causes COVID-19 in humans.
3. Dosage and administration
Puppies: Initial vaccination is recommended at 6-8 weeks of age, followed by booster doses as advised by a veterinarian.
Adult Dogs: Annual revaccination is recommended to maintain immunity.
Dosage: 1ml for intramuscular or subcutaneous use only.
Vaccine should be administered observing aseptic precautions.
It’s safe to use with other commonly used vaccines.
Overdosing is generally safe, with twice the recommended dose also being well-tolerated in target species.
Important: Consult with your veterinarian for the appropriate vaccination schedule and administration procedures for your dog.